What is Pfizer's finished goods?

Pfizer (PFE) reported finished goods of $4.03B in Q1 2026.

How has Pfizer's finished goods changed year-over-year?

Pfizer's finished goods decreased by 3.1% year-over-year, from $4.16B to $4.03B.

What is the long-term trend for Pfizer's finished goods?

Over 5 years (2020 to 2025), Pfizer's finished goods has grown at a 7.4% compound annual growth rate (CAGR), from $2.88B to $4.11B.

Pfizer PFE Finished goods

Finished goods at other companies

AmgenAMGN

——

IncyteINCY

——

AbbVieABBV

——

ModernaMRNA

——

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$137.24B+0.6%

Enterprise value$199.91B+1.7%

P/E11.3×—

P/S2.2×0.0×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

FCF margin18%+8.8pp

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's finished goods?: Pfizer (PFE) reported finished goods of $4.03B in Q1 2026.
How has Pfizer's finished goods changed year-over-year?: Pfizer's finished goods decreased by 3.1% year-over-year, from $4.16B to $4.03B.
What is the long-term trend for Pfizer's finished goods?: Over 5 years (2020 to 2025), Pfizer's finished goods has grown at a 7.4% compound annual growth rate (CAGR), from $2.88B to $4.11B.